ADVOONC Trademark

Trademark Overview

On Wednesday, October 8, 2025, a trademark application was filed for ADVOONC with the United States Patent and Trademark Office. The USPTO has given the ADVOONC trademark a serial number of 99433346. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 3, 2026. This trademark is owned by A2CL Services, LLC. The ADVOONC trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Genetic testing for medical purposes; Genetic testing for medical purposes in the field of hereditary cancer screening; Medical testing services for predicting hereditary cancer and identifying risk factors of hereditary cancer
advoonc

General Information

Serial Number99433346
Word MarkADVOONC
Filing DateWednesday, October 8, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, March 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2026

Trademark Statements

Goods and ServicesGenetic testing for medical purposes; Genetic testing for medical purposes in the field of hereditary cancer screening; Medical testing services for predicting hereditary cancer and identifying risk factors of hereditary cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 8, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameA2CL Services, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWest Allis, WI 53227
US

Trademark Events

Event DateEvent Description
Wednesday, October 8, 2025NEW APPLICATION ENTERED
Wednesday, October 8, 2025APPLICATION FILING RECEIPT MAILED
Sunday, October 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 26, 2026ASSIGNED TO EXAMINER
Friday, February 27, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

advoonc hereditary medical cancer testing purposes genetic risk identifying factors screening